CASI Pharmaceuticals (CASI) Cash & Current Investments (2021 - 2025)
Historic Cash & Current Investments for Pharmaceuticals (CASI) over the last 5 years, with Q2 2025 value amounting to $6.7 million.
- Pharmaceuticals' Cash & Current Investments rose 7060177.28% to $6.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.7 million, marking a year-over-year increase of 7060177.28%. This contributed to the annual value of $13.5 million for FY2024, which is 5370.87% down from last year.
- According to the latest figures from Q2 2025, Pharmaceuticals' Cash & Current Investments is $6.7 million, which was up 7060177.28% from $10897.0 recorded in Q1 2025.
- In the past 5 years, Pharmaceuticals' Cash & Current Investments registered a high of $19.9 billion during Q2 2023, and its lowest value of $9533.0 during Q2 2024.
- Its 5-year average for Cash & Current Investments is $2.2 billion, with a median of $13.5 million in 2024.
- In the last 5 years, Pharmaceuticals' Cash & Current Investments crashed by 10000.0% in 2024 and then soared by 7060177.28% in 2025.
- Quarter analysis of 5 years shows Pharmaceuticals' Cash & Current Investments stood at $48.6 million in 2021, then increased by 0.0% to $48.6 million in 2022, then plummeted by 40.1% to $29.1 million in 2023, then plummeted by 53.71% to $13.5 million in 2024, then tumbled by 49.96% to $6.7 million in 2025.
- Its Cash & Current Investments stands at $6.7 million for Q2 2025, versus $10897.0 for Q1 2025 and $13.5 million for Q4 2024.